Pharmaco-economics – is it relevant to prescribers?

Por Keen, P J
Publicado em 1994

Pharmaco-economic issues in the treatment of severe osteoporosis

Por Piscitelli, Prisco, Chitano, Giovanna, Greco, Marco, Benvenuto, Marco, Sbenaglia, Enzo, Colì, Giuseppe, Migliore, Alberto, Granata, Mauro, Iolascon, Giovanni, Gimigliano, Raffaele, Baggiani, Angelo, Distante, Alessandro, Tarantino, Umberto, Rizzuti, Carla, Brandi, Maria Luisa
Publicado em 2010

PHARMACO-ECONOMICAL ASPECTS OF IN-PATIENT TREATMENT OF CHILDREN WITH PERINATAL

Por N.M. Sudakova, N.I. Grevtseva, I.V. Kareva, O.M. Zubov
Publicado em 2012-02-01

Pharmaco-economical analysis of Russian QUADRIGA Study data

Por A. A. Kuprina, Yu. B. Belousov
Publicado em 2006-04-01

Pharmaco-Economic Aspects of Antibiotic Prescriptions in Clinics of Kathmandu

Por Akhilesh Chandra Jauhari, A Pokharel, N Palikharel, N Shrestha, BS Rao
Publicado em 2004-03-01

Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value

Por Zoons, E., Dijkgraaf, M. G. W., Dijk, J. M., van Schaik, I. N., Tijssen, M. A.
Publicado em 2012

Clinical and pharmaco-economical effectiveness of hospital-replacing technologies in cardiology

Por Ya. I. Kotz, M. V. Stolbova
Publicado em 2007-08-01

PHARMACO-ECONOMIC EVALUATION OF THE USE OF VALPROATES IN TABLET FORMS IN EPILEPSY THERAPY

Por P. A. Balunov
Publicado em 2017-05-01

Secondary prevention of acute cerebrovascular failures - pharmaco-economical aspects of problem

Por A. V. Rudakova
Publicado em 2007-10-01

Pharmaco-economic and market analysis of ATE-inhibitor in the treatment of hypertension in the hospital

Por O. P. Balitska
Publicado em 2014-02-01

Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France

Por Boecking, Wolfgang, Klamar, Anna, Kitzmann, Florian, Kirch, Wilhelm
Publicado em 2012

Pharmaco-economic ABC/VEN analysis of pre-hospital hypertensive crise treatment

Por S. V. Mal’chikova, E. I. Tarlovskaya
Publicado em 2010-04-01

Pharmaco-economic analysis of adjuvant chemotherapy for stage II and III colorectal cancer

Por Iwai, Mina, Kimura, Michio, Usami, Eiseki, Yoshimura, Tomoaki, Teramachi, Hitomi
Publicado no Mol Clin Oncol (2017)

COPD a social disease: inappropriateness and pharmaco-economics. The role of the specialist: present and future

Por Donner, Claudio F, Lusuardi, Mirco
Publicado em 2010

Pharmaco-economics: Minute-based cost of sevoflurane in pediatric short procedures and its relation to demographic variables

Por Singh, Preet Mohinder, Trikha, Anjan, Sinha, Renu, Ramachandran, Rashmi, Rewari, Vimi, Borle, Anuradha
Publicado em 2013

PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION

Por A. V. Syrov, S. K. Zyryanov, Yu. B. Belousov
Publicado em 2010-04-01

Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems - a new approach

Por Wilke, MH, Grube, R
Publicado em 2010

Economic Evaluation of Pharmaco- and Behavioral Therapies for Smoking Cessation: A Critical and Systematic Review of Empirical Research

Por Ruger, Jennifer Prah, Lazar, Christina M.
Publicado em 2012

A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours

Por Contreras-Hernández, I, Mould-Quevedo, J F, Silva, A, Salinas-Escudero, G, Villasís-Keever, M A, Granados-García, V, Dávila-Loaiza, G, Petersen, J A, Garduño-Espinosa, J
Publicado em 2008

A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss

Por Treur, Maarten, Heeg, Bart, Möller, Hans-Jürgen, Schmeding, Annette, van Hout, Ben
Publicado em 2009